CPRiL

C25H29BrN4O2

C[C@@H](CN1CCC(CC1)N2C3=C(C=C(C=C3)Br)NC2=O)NC(=O)[C@@H]4C[C@H]4C5=CC=CC=C5

InChI=1S/C25H29BrN4O2/c1-16(27-24(31)21-14-20(21)17-5-3-2-4-6-17)15-29-11-9-19(10-12-29)30-23-8-7-18(26)13-22(23)28-25(30)32/h2-8,13,16,19-21H,9-12,14-15H2,1H3,(H,27,31)(H,28,32)/t16-,20-,21+/m0/s1

• 1246303-14-9
• VU0359595
• Cyclopropanecarboxamide, N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-, (1R,2R)-
ML270
CHEMBL524182
(1R,2R)-N-((S)-1-(4-(5-Bromo-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-phenylcyclopropanecarboxamide
(1R,2R)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-cyclopropanecarboxamide
(1R,2R)-N-[(2S)-1-[4-(5-Bromo-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide
VU-0359595
VU0359595-1
VU 0359595;VU0359595
SCHEMBL10277051
BDBM87119
cid_53470193
GLXC-02716
WZB30314
BDBM50257541
EX-A11064
AKOS027320660
NCGC00386841-03
NCGC00386841-04
DA-59075
MS-29232
HY-101293
CS-0021093
G14167
VU0359595 (2)
VU0359595, >=97% (HPLC)
(1r,2r)-N-([s]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1h-benzo(d)imidazol-1-yl]piperidin-1-yl} propan-2-yl)-2-phenylcyclopropanecarboxamide
(1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide (Inh_VU0359595)